New Leaf Venture Partners
Venture capitalNew York · Seed–Late Stage · 7 people tracked
Also known as NEW LEAF VENTURE PARTNERS LLC
Investment thesis
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.
Source: firm website, verified Aug 25, 2026.
Team · 7 people
from curated & public directories
What they invest in
from 17 of 20 portfolio companiesHealthtech ×9Biotech ×8Medical Devices ×5Digital Health ×4AI & Machine Learning ×3SaaS ×2Data & Infrastructure ×1Enterprise Software ×1
HQs:United States×18
Investments · 20 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 12022 · 12017 · 32016 · 32015 · 22014 · 214 dated
iRhythm provides wearable cardiac monitoring devices and AI-powered analysis services for clinicians to diagnose heart arrhythmias.
AI & Machine LearningHealthtechMedical DevicesSan Francisco, US
Kevin M. King(Executive Officer, Director)Shelly D. Guyer(Executive Officer)William F. Willis(Executive Officer, Director)Judith Lenane(Executive Officer)Steve Johnson(Executive Officer)
BoardTiba Aynechi(Director)in
Board seatVijay Lathi· per SEC Form D · $29.5M raise · filed Mar 2015
Co-investorsKaiser Permanente VenturesNorwest Venture Partners
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCPappas Capital+2 more
New York, US
Michael Liang(Director)Gordon Kessler(Executive Officer)Rick Hawkins(Director)Adam Hanina(Executive Officer, Director)
Board seatVijay Lathi· per SEC Form D · $12M raise · filed Jul 2017
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)Dana Mead(Director)
Board seatVijay Lathi· per SEC Form D · $1.9M raise · filed Aug 2017
Co-investorsIcon VenturesRex Health VenturesHERITAGE HEALTHCARE INNOVATIONKleiner PerkinsVenrock
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Executive Officer, Director)in
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)Louis Samson(Director)
Board seatVijay Lathi· per SEC Form D · $16.8M raise · filed Mar 2022
Co-investorsBattery VenturesBreyer CapitalInsight PartnersLRVHealthVensana Capital
Barricaid develops a bone-anchored implant designed to reduce reherniation and reoperation in patients undergoing discectomy for large annular defects.
HealthtechMedical DevicesWoburn, US
Gregory H. Lambrecht(Director)Carey Hagan(Executive Officer, Director)Cary Hagan(Executive Officer, Director)
BoardRyan Drant(Director)inJoshua Makower(Director)
Board seatJeani Delagardelle· per SEC Form D · $7.5M raise · filed Apr 2023
Co-investorsDelos CapitalNew Enterprise Associates (NEA)Questa CapitalGreenspring Associates
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtechWashington, US
Kevin MacDonald(Executive Officer)Timothy Kress-Spatz(Executive Officer)
Board seatVijay Lathi· per SEC Form D · filed Jun 2016
Co-investorsEaston CapitalKaiser Permanente VenturesLionBirdRex Health VenturesRock Health
Kyruus Health provides a healthcare access platform that unifies provider and member data to help patients find, schedule, and access care.
Digital HealthHealthtechSaaSBoston, US
Graham Gardner(Executive Officer, Director)Julie Yoo(Executive Officer, Director)Graham Gardner, MD, MBA(Founder)in
BoardRobert Paull(Director)Robert Higgins(Director)Bryan Roberts(Director)
Board seatVijay Lathi· per SEC Form D
Co-investorsFrancisco PartnersTRANSFORMATION CAPITALVenrockHighland Capital PartnersLux CapitalVenrock Associates
BiotechSan Clemente, US
Richard Thompson(Executive Officer, Director)
BoardCasey Tansey(Director)David Milne(Director)John Lehmann, M.D.(Director)Kenneth Charhut(Director)
Board seatJeani Delagardelle· per SEC Form D · $8.8M raise · filed Mar 2015
Co-investorsUS Venture Partners
Truveris offers a technology platform with claims analytics and PBM (pharmacy benefit manager) oversight to reduce pharmacy benefit costs through contract optimization for employers.
Data & InfrastructureDigital HealthHealthtechSaaSNew York, US
Anthony Joseph Loiacono(Executive Vice-President, Sales and Marketing)Michael Facendola(Executive Officer)Louise Shea(Chief Pharmacy Officer)inLeon Stewart Greene(Executive Vice-President, Operations)Bryan Birch(Chief Executive Officer)
BoardPhilippe Chambon(Director)
Board seatVijay Lathi· per SEC Form D
Co-investorsCanaan PartnersMcKesson VenturesNAV.VCTribeca Venture Partners
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
HealthtechMenlo Park, US
Lou Bock(Director)Brett Hale(Executive Officer)Casey Tansey(Director)Frank Gentile(Director)Maria Sainz(Executive Officer, Director)Eric Fain(Director)
Co-investorsArcher Capital GroupArcher Venture CapitalSV Health InvestorsSV Life Sciences
BiotechSan Carlos, US
Anthony P. Ford(Executive Officer, Director)Benjamin Potter(Executive Officer)Henry Skinner(Director)Liam Ratcliffe(Director)
BoardRon Hunt(Director)Loretta Tse, Ph.D.(Director)
Co-investorsAlta Partners
Cambridge, US
Annalisa Jenkins(Executive Officer, Director)
BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)
Co-investorsF-Prime CapitalOrbiMed
HealthtechSanta Rosa, US
Dan Rose(Executive Officer)Gordon Bishop(Executive Officer, Director)David Boyle(Executive Officer)Dan T. Lemaitre(Executive Officer, Director)Chris Richardson(Executive Officer)
BoardYuval Binur(Director)
Co-investorsSV Health InvestorsFOUNDATION MEDICAL PARTNERS
Flosonics Medical makes FloPatch, a wireless wearable Doppler ultrasound device that assesses a patient's carotid arterial pulse in real time to give clinicians hemodynamic data for fluid resuscitation decisions.
Digital HealthHardwareMedical Devices
Joe Eibl(Founder)in
Co-investorsAmplify CapitalArboretum VenturesGenesys CapitaliGan PartnersRBCx
Cambridge, MA biotechnology company developing injectable synthetic biomarkers for noninvasive disease staging and treatment monitoring.
BiotechCambridge, US
Gabriel Kwong(Executive Officer)Sirshendu Roopom Banerjee(Executive Officer)
BoardTheresia Guow(Director)Amy Schulman(Director)inStan Lapidus(Director)
Co-investorsGreatPoint VenturesAcrew CapitalAspect VenturesCatalio Capital ManagementDns CapitalPolaris Partners+2 more
BiotechSouth San Francisco, US
MARTIN BABLER(Executive Officer, Director)
BoardPETER THOMPSON(Director)SRINIVAS AKKARAJU(Director)MICHAEL DYBBS(Director)inSIMEON GEORGE(Director)LEWIS J. SHUSTER(Director)
Co-investorsAccess BiotechnologyMission BiocapitalSofinnova VenturesMission Bay CapitalOrbiMedSamsara BioCapital
Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions.
BiotechMedical DevicesDedham, US
Thurein Htoo(Executive Officer, Director)Fred Guerard(President & Chief Executive Officer)Barbara Wirostko(Executive Officer)
BoardWende Hutton(Director)inRonald M. Hunt(Director)Andrew Danielson(Director)
Co-investorsCanaan Partnersabrdn plcCorrelation VenturesMayo Clinic Ventures
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inJason Hafler(Director)Nancy Stagliano(Director)Michelle Carpenter(Executive Officer)Matthew Fust(Director)Amrit Nagpal(Director)
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioIrhythmtechNASDAQ: IRTC
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Star Therapeutics · pharmaceutical-technology.com · Oct 1, 2025
Kyruus · mobihealthnews.com · Sep 24, 2025
Flosonics Medical · massdevice.com · Mar 3, 2025
Curasen · nasdaqprivatemarket.com · Mar 2, 2025
Frequently asked questions
- What stage does New Leaf Venture Partners invest at?
- New Leaf Venture Partners invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does New Leaf Venture Partners focus on?
- New Leaf Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is New Leaf Venture Partners located?
- New Leaf Venture Partners is headquartered in New York, US.
Co-investors · 19
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
SV Health Investors is a healthcare-focused investment firm that invests across multiple stages, geographies and healthcare sectors.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Johnson & Johnson Innovation is the innovation arm of Johnson & Johnson, working to advance life science innovation through early partnerships, incubation via JLABS, venture investing through JJDC, and late-stage partnerships to address global health challenges.
Bain Capital Life Sciences, founded in 2016, invests in biopharmaceutical, medical device, diagnostic, and life science tool companies globally, focusing on companies addressing unmet medical needs and driving medical innovation.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Goodwater Capital is a consumer technology investment firm backing entrepreneurs building companies across sectors such as housing, healthcare, food delivery, financial services, education, entertainment, and transportation.
Wildcat Venture Partners is a venture capital firm that backs technology entrepreneurs aiming to create new market categories.
Versant Ventures operates in-house Discovery Engines staffed by multidisciplinary scientists in dedicated laboratory facilities to help launch new biotechnology companies alongside academic founders.
▶7 more co-investors
5AM VenturesDomain AssociatesFrazier Healthcare PartnersNextech InvestLightstone VenturesVantagePoint Capital Partners4see Ventures
Firms observed investing alongside New Leaf Venture Partners, from public investor directories. Shared companies are the overlap with New Leaf Venture Partners's recorded portfolio.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.